Evidence map›Paper›PMID 22970173›Full record

ArticlePloS one2012

Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease.

Jane J Sohn, Aaron J Schetter, Harris G Yfantis, Lisa A Ridnour, Izumi Horikawa, Mohammed A Khan, Ana I Robles, S Perwez Hussain, Akiteru Goto, Elise D Bowman and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Pig-Derived ProbioticAnimals : an open access journal from MDPI · 2024
    Article
  7. Review
  8. Article
  9. Cellular Senescence, Inflammation, and Cancer in the Gastrointestinal Tract.International journal of molecular sciences · 2023
    Review
  10. International journal of molecular sciences · 2023
    Review
  11. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?International journal of molecular sciences · 2023
    Review
  12. Review
  13. Nutrients · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Jane J SohnLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
Aaron J Schetter
Harris G Yfantis
Lisa A Ridnour
Izumi Horikawa
Mohammed A Khan
Ana I Robles
S Perwez Hussain
Akiteru Goto
Elise D Bowman
Lorne J Hofseth
Jirina Bartkova
Jiri Bartek
Gerald N Wogan
David A Wink
Curtis C Harris
National Cancer Institute · USCenter for Cancer Research · USCenter for Environmental Health · USDanish Cancer Society · DKInstitute of Molecular and Translational Medicine · CZUniversity of Maryland, Baltimore · USUniversity of South Carolina · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

backgroundCellular senescence can be a functional barrier to carcinogenesis. We hypothesized that inflammation modulates carcinogenesis through senescence and DNA damage response (DDR). We examined the association between senescence and DDR with macrophage levels in inflammatory bowel disease (IBD). In vitro experiments tested the ability of macrophages to induce senescence in primary cells. Inflammation modulating microRNAs were identified in senescence colon tissue for further investigation. METHODOLOGY/PRINCIPAL

findingsQuantitative immunohistochemistry identified protein expression by colon cell type. Increased cellular senescence (HP1γ; P = 0.01) or DDR (γH2A.X; P = 0.031, phospho-Chk2, P = 0.014) was associated with high macrophage infiltration in UC. Co-culture with macrophages (ANA-1) induced senescence in >80% of primary cells (fibroblasts MRC5, WI38), illustrating that macrophages induce senescence. Interestingly, macrophage-induced senescence was partly dependent on nitric oxide synthase, and clinically relevant NO• levels alone induced senescence. NO• induced DDR in vitro, as detected by immunofluorescence. In contrast to UC, we noted in Crohn's disease (CD) that senescence (HP1γ; P<0.001) and DDR (γH2A.X; P<0.05, phospho-Chk2; P<0.001) were higher, and macrophages were not associated with senescence. We hypothesize that nitric oxide may modulate senescence in CD; epithelial cells of CD had higher levels of NOS2 expression than in UC (P = 0.001). Microarrays and quantitative-PCR identified miR-21 expression associated with macrophage infiltration and NOS2 expression.

conclusionsSenescence was observed in IBD with senescence-associated β-galactosidase and HP1γ. Macrophages were associated with senescence and DDR in UC, and in vitro experiments with primary human cells showed that macrophages induce senescence, partly through NO•, and that NO• can induce DDR associated with senescence. Future experiments will investigate the role of NO• and miR-21 in senescence. This is the first study to implicate macrophages and nitrosative stress in a direct effect on senescence and DDR, which is relevant to many diseases of inflammation, cancer, and aging.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCells, CulturedCellular SenescenceCheckpoint Kinase 2Chromosomal Proteins, Non-HistoneColitis, UlcerativeColonCrohn DiseaseCyclin-Dependent Kinase Inhibitor p21DNA DamageEpithelial CellsFibroblastsHistonesAntigens, CDAntigens, Differentiation, MyelomonocyticCBX3 protein, humanCD68 antigen, humanCD68 MoleculeCheckpoint Kinase 2CHEK2 protein, humanChek2 protein, mouseChromosomal Proteins, Non-HistoneCyclin-Dependent Kinase Inhibitor p21H2AX protein, humanHistonesMicroRNAsNitric OxideNitric Oxide Synthase Type IINOS2 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID22970173
PMCPMC3435404
OpenAlexW2104613732

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.